nach oben

Zeitschrift für Rheumatologie

Erschienen in:

12.11.2015 | Originalien

Relationship of osteoprotegerin to pulse wave velocity and carotid intima-media thickness in rheumatoid arthritis patients

verfasst von: M.S. Beyazal, MD, T. Erdoğan, G. Devrimsel, A.K. Türkyılmaz, M.C. Cüre, M. Beyazal, I. Sahin

Erschienen in: Zeitschrift für Rheumatologie | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective

Osteoprotegerin (OPG) is considered an important biomarker in cardiovascular (CV) disease. CV disease is the most common cause of mortality in patients with rheumatoid arthritis (RA), a consequence of accelerated atherosclerosis. The present study aimed to evaluate the relationship of serum OPG levels to arterial stiffness, carotid intima-media thickness (CIMT), and clinical and laboratory indices in RA patients.

Patients and methods

Included in the study were 68 RA patients with no history or signs of CV disease and 48 healthy subjects Disease activity was assessed by the 28-joint disease activity score (DAS28) in RA patients. Serum OPG level was measured using enzyme-linked immunosorbent assay (ELISA). Carotid femoral pulse wave velocity (PWV) was measured as an index of arterial stiffness and CIMT was evaluated by carotid ultrasonography.

Results

The mean serum OPG level was significantly higher in RA patients than controls (p < 0.001). Mean PWV and CIMT were also significantly increased in RA patients compared to controls (both p < 0.001). In RA patients, serum OPG level was significantly correlated with PWV and CIMT, as well as rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibody; but not with DAS28, high-sensitivity C-reactive protein (hsCRP), or erythrocyte sedimentation rate.

Conclusion

Serum OPG levels were increased and correlated with CIMT and PWV in RA patients. In addition to PWV and CIMT, OPG may be a useful biomarker for CV risk management in RA patients.

Tanasescu C, Jurcut C, Jurcut R et al (2009) Vascular disease in rheumatoid arthritis: from subclinical lesions to cardiovascular risk. Eur J Intern Med 20:348–354CrossRefPubMed

Peters MJ, Symmons DP, McCarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325–331CrossRefPubMed

Han C, Robinson DWJ, Hackett MV et al (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172PubMed

Roman MJ, Devereux RB, Schwartz JE et al (2005) Arterial stiffness in chronic inflammatory diseases. Hypertension 46:194–199CrossRefPubMed

Roman MJ, Moeller E, Davis A, et al (2006) Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 144:249–256CrossRefPubMed

Solomon DH, Karlson EW, Rimm EB et al (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107:1303–1307CrossRefPubMed

Turesson C, Jarenros A, Jacobsson L (2004) Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis 63:952–955CrossRefPubMedPubMedCentral

Vaudo G, Marchesi S, Gerli R et al (2004) Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 6:31–35CrossRef

Dessein PH, Norton GR, Woodiwiss AJ et al (2007) Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol 34:943–951PubMed

10.

Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR et al (2008) Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum 38(2):67–70CrossRefPubMed

11.

Kumeda Y, Inaba M, Goto H et al (2002) Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 46:1489–1497CrossRefPubMed

12.

Park YB, Ahn CW, Choi HK et al (2002) Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 46:1714–1719CrossRefPubMed

13.

Fan F, Galvin A, Fang L et al (2014) Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease. J Inflamm 11(1):29CrossRef

14.

Boutouyrie P, Tropeano AI, Asmar R et al (2002) Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 39(1):10–15CrossRefPubMed

15.

Venuraju SM, Yerramasu A, Corder R et al (2010) Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J Am Coll Cardiol 55(19):2049–2061CrossRefPubMed

16.

Asanuma Y, Chung CP, Oeser A et al (2007) Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis 195(2):135–141CrossRef

17.

Aletaha D, Neogi T, Silman AJ et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581CrossRefPubMed

18.

Prevoo ML, Hof MA van’t, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48CrossRefPubMed

19.

Soeiro Ade M, Haddad M, Almeida MC de et al (2012) Rheumatoid arthritis and cardiovascular disease: what is known about this relationship and what can currently be done for affected patients? Rev Port Cardiol 31(3):225–232

20.

Halm VP van, Peters MJ, Voskuyl AE et al (2009) Rheumatoid arthritis versus type 2 diabetes as a risk factor for cardiovascular disease: a cross-sectional study. Ann Rheum Dis 68:1395–1400CrossRefPubMed

21.

Nurmohamed MT (2009) Cardiovascular risk in rheumatoid arthritis. Autoimmun Rev 8(8):663–667CrossRefPubMed

22.

Stamatelopoulos KS, Kitas GD, Papamichael CM et al (2010) Subclinical peripheral arterial disease in rheumatoid arthritis. Atherosclerosis 212(1):305–309CrossRefPubMed

23.

Carotti M, Salaffi F, Mangiacotti M et al (2007) Atherosclerosis in rheumatoid arthritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness. Reumatismo 59:38–49PubMed

24.

Rincón I del, Freeman GL, Haas RW et al (2005) Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 52:3413–3423CrossRefPubMed

25.

Gonzalez-Gay MA, Gonzalez-Juanatey C, Piñeiro A et al (2005) High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 32:1219–1223PubMed

26.

Rincón I del, Williams K, Stern MP et al (2003) Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 48:1833–1840CrossRefPubMed

27.

Jain S, Khera R, Corrales-Medina VF, Townsend RR et al (2014) Inflammation and arterial stiffness in humans. Atherosclerosis 237(2):381–390CrossRefPubMed

28.

Roman MJ, Devereux RB, Schwartz JE et al (2005) Arterial stiffness in chronic inflammatory diseases. Hypertension 46:194–199CrossRefPubMed

29.

Pieringer H, Stuby U, Pohanka E et al (2010) Arterial stifness in a muscular artery in women with longstanding rheumatoid arthritis compared with healthy controls and patients with traditional cardiovascular risk factors. Rheumatol Int 30:1335–1339CrossRefPubMed

30.

Mäki-Petäjä KM, Hall FC, Booth AD et al (2006) Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-α therapy. Circulation 114:1185–1192CrossRefPubMed

31.

Klocke R, Cockcroft JR, Taylor GJ et al (2003) Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis 62:414–418CrossRefPubMedPubMedCentral

32.

Arosio E, De Marchi S, Rigoni A et al (2007) Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis. J Hypertens 25:1273–1278CrossRefPubMed

33.

Turesson C, Jacobsson L, Rydén Ahlgren A et al (2005) Increased stiffness of the abdominal aorta in women with rheumatoid arthritis. Rheumatology 44:896–901CrossRefPubMed

34.

Van Campenhout A, Golledge J (2009) Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 204(2):321–329CrossRef

35.

Hosbond SE, Poulsen TS, Diederichsen AC et al (2012) Osteoprotegerin as a marker of atherosclerosis: a systematic update. Scand Cardiovasc J 46(4):203–211CrossRefPubMed

36.

Asanuma YF, Shimada Y, Kouzu N et al (2013) Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis. Mod Rheumatol 23(2):269–275CrossRefPubMed

37.

Dessein PH, López-Mejias R, González-Juanatey C et al (2014) Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis. J Rheumatol 41(3):429–436CrossRefPubMed

Titel: Relationship of osteoprotegerin to pulse wave velocity and carotid intima-media thickness in rheumatoid arthritis patients
verfasst von: M.S. Beyazal, MD
T. Erdoğan
G. Devrimsel
A.K. Türkyılmaz
M.C. Cüre
M. Beyazal
I. Sahin
Publikationsdatum: 12.11.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Zeitschrift für Rheumatologie / Ausgabe 7/2016
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI: https://doi.org/10.1007/s00393-015-1675-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Bildnachweise

Die Leitlinien für Ärztinnen und Ärzte, Digitale Mammographien links in kraniokaudaler Projektion./© Weigel, S. et al. / all rights reserved Springer Medizin Verlag GmbH, Operation bei Blasenkrebs/© anistidesign / Fotolia, Medizinische Fachangestellte sitzt erschöpft auf der Treppe/© Courtney Haas / peopleimages.com /stock.adobe.com (Symbolbild mit Fotomodell), Mann wird von Ärztin untersucht/© Tashi-Delek, Getty Images, iStock (Symbolbild mit Fotomodellen)

Springer Medizin

Abstract

Objective

Patients and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2016

Wissenschaftsbetrug

Treatment of IgG4-related disease

Update Rheumatologie

Kurt Seidel (1914–1990)

Knochen- und Fettgewebebildung